Ausgabe 1/2019
Special Issue: Towards Pharmacogenetic-based Treatment in Psychiatry
Inhalt (11 Artikel)
Towards pharmacogenetic-based treatment in psychiatry
Chad A. Bousman, Andreas Menke, Daniel J. Müller
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes
Sam Mostafa, Carl M. J. Kirkpatrick, Keith Byron, Leslie Sheffield
Genetic variations in the ADCK1 gene predict paliperidone palmitate efficacy in Han Chinese patients with schizophrenia
Yun-Ai Su, Chad Bousman, Qian Li, Ji-Tao Li, Jing-Yu Lin, Tian-Mei Si
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
Malgorzata Maciukiewicz, Ilona Gorbovskaya, Arun K. Tiwari, Clement C. Zai, Natalie Freeman, Herbert Y. Meltzer, James L. Kennedy, Daniel J. Müller
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression
Azmeraw T. Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, Yi-Hsiang Hsu, Katrin Sangkuhl, Gregory Jenkins, Ryan M. Whaley, Poulami Barman, Anthony Batzler, Russ B. Altman, Volker Arolt, Jürgen Brockmöller, Chia-Hui Chen, Katharina Domschke, Daniel K. Hall-Flavin, Chen-Jee Hong, Ari Illi, Yuan Ji, Olli Kampman, Toshihiko Kinoshita, Esa Leinonen, Ying-Jay Liou, Taisei Mushiroda, Shinpei Nonen, Michelle K. Skime, Liewei Wang, Masaki Kato, Yu-Li Liu, Verayuth Praphanphoj, Julia C. Stingl, William V. Bobo, Shih-Jen Tsai, Michiaki Kubo, Teri E. Klein, Richard M. Weinshilboum, Joanna M. Biernacka, Bernhard T. Baune
Blood-based biomarkers predicting response to antidepressants
Yasmin Busch, Andreas Menke
Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literature
Victoria S. Marshe, Ilona Gorbovskaya, Sarah Kanji, Maxine Kish, Daniel J. Müller
The role of depression pharmacogenetic decision support tools in shared decision making
Katarina Arandjelovic, Harris A. Eyre, Eric Lenze, Ajeet B. Singh, Michael Berk, Chad Bousman
Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial
J. M. Menchón, J. Espadaler, M. Tuson, J. Saiz-Ruiz, J. Bobes, E. Vieta, E. Álvarez, V. Pérez
Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
Hilario Blasco-Fontecilla
Application of pharmacogenetics in clinical practice: problems and solutions
Andrius Baskys